For more than 37 years, he has held numerous R&D, manufacturing, quality, business development and executive leadership roles at Johnson & Johnson, Eli Lilly and Company, Bausch & Lomb, and Microbiology Consultants, LLC. In his current role, Dr. Miller advises multinational companies in the areas of microbiology, quality and regulatory affairs in support of rapid methods, sterile and non-sterile pharmaceutical manufacturing and contamination control. He has also served as an expert witness on numerous pharmaceutical and medical device patent and product liability legal cases.
Dr. Miller has authored more than 100 technical publications and presentations and currently serves on the editorial and scientific review boards for American Pharmaceutical Review, European Pharmaceutical Review and the PDA Journal of Pharmaceutical Science and Technology. Dr, Miller is the chairperson for the PDA Technical Report #33 revision: and has served as an advisor to the USP Microbiology Expert Committee in the area of rapid sterility testing.
Dr. Miller holds a Ph.D. in Microbiology and Biochemistry from Georgia State University, and a B.A. in Anthropology and Sociology from Hobart College.
